PamelaTaxelMD
Endocrinology • Farmington, CTDiabetes, Lipid Metabolism, Osteoporosis & Bone Metabolism Medicine
Professor, Medicine, University of Connecticut SOM
Dr. Taxel is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
263 Farmington Ave
Farmington, CT 06030Phone+1 860-679-2160Fax+1 860-679-1422- Is this information wrong?
Education & Training
University of ConnecticutFellowship, Geriatric Medicine (Internal Medicine), 1995 - 1996- University of ConnecticutFellowship, Endocrinology, Diabetes, and Metabolism, 1993 - 1995
University of South Florida MorsaniResidency, Internal Medicine, 1989 - 1991
State University of New York Downstate Medical Center College of MedicineClass of 1989
Certifications & Licensure
FL State Medical License 1991 - 2026
CT State Medical License 1995 - 2024
Clinical Trials
- Anastrozole and Letrozole Start of enrollment: 2007 May 01
- Effect Of Risedronate On Bone Mass In Older Men Receiving Neoadjuvant Therapy For Prostate Cancer Start of enrollment: 2003 Jan 01
Publications & Presentations
PubMed
- 1 citationsDental implant and bone augmentation treatment in bone-compromised patients: Oral health-related quality of life outcomes.Jonathan F Leonard, Pamela Taxel, Chia-Ling Kuo, Lucas Da Cunha Godoy, Martin Freilich> ;The Journal of Prosthetic Dentistry. 2023 Feb 18
- 32 citationsThe prevention of osteoporosis and sarcopenia in older adultsPatrick P. Coll, Steven Phu, Samah H. Hajjar, Ben Kirk, Gustavo Duque, Pamela Taxel> ;Journal of the American Geriatrics Society. 2021 Feb 23
- 8 citationsPhysical activity and health-related quality of life among postmenopausal women with breast cancer treated with aromatase inhibitorsKate E. Dibble, Keith M. Bellizzi, Pamela Taxel, Linda S. Pescatello, Elizabeth J. Siembida, Elizabeth D. Schifano, S. Guarneri, Susan Tannenbaum> ;Supportive Care in Cancer. 2021 May 1
- Join now to see all
Grant Support
- Clinical Trial: The Effect Of Risedronate On Bone Turnover And Bone Mass In OldeNational Center For Research Resources2008
- AnastrozoleNational Center For Research Resources2008
- Effects Of Oral Estradiol Therapy On OsteoclastogenesisNational Center For Research Resources2004–2008
- The Effect Of Risedronate On Bone Turnover And Bone Mass In Older Men ReceivingNational Center For Research Resources2005–2007
- Effect Of Letrozole On Bone Markers And Blood PressureNational Center For Research Resources2005–2007
- Acute Estrogen In WomenNational Center For Research Resources2004–2007
- AlendronateNational Center For Research Resources2004–2006
- Men On Lupron For Prostate CancerNational Center For Research Resources2004
- Effect Of Risedronate On Bone Turnover /Bone Mass In MenNational Center For Research Resources2004
- Effect Of Oral Estrogen Therapy On Bone Turnover And BONNational Center For Research Resources2004
- Estrogen Regulation Of Osteoclastogenesis In Older MenNational Institute On Aging2003
- Effect Of Estrogen On Bone Turnover In Older Men With Low Bone MassNational Center For Research Resources1998–2002
- Effect Of Aromatase Inhibition On Bone Turnover In Older MenNational Center For Research Resources1998–2002
- Estrogen Therapy On Bone Turnover &Mass In Men With Prostate CancerNational Center For Research Resources2000
- Gcrc-Cap-Effect Of Estrogen On Bone Turnover In Older Men With Low Bone MassNational Center For Research Resources1997
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
